Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Thank you for subscribing to CAS life sciences updates
You can look forward to monthly emails where we share the latest drug development and life sciences articles on CAS Insights™, our thought leadership blog, as well as behind-the-scenes information about new content in the CAS Content CollectionTM and capabilities in CAS solutions.
CAS is proud to be part of your drug development innovation journey.
Learn how you can benefit from our life sciences content in your current CAS solutions.
Latest from CAS Insights™
Biotechnology
Microelectronics frontiers: insights into emerging technologies
How can researchers identify emerging trends in a massive field like microelectronics? Our analysis reveals breakthroughs across materials, devices, applications, and fabrication methods.
Biotechnology
The future of epigenetics: Emerging technologies and clinical applications
Epigenetics is the study of changes in gene expression that don’t alter DNA sequences. Understanding these processes is driving more personalized medicine and innovative therapies.